Clinical Trials
29 trialsStudy on the Mechanism of ADC Drug Evaluation Based on Immune Co-culture of Lung Cancer Organoids
Guangzhou Institute of Respiratory Disease
Neoadjuvant Becotatug Vedotin Plus Pucotenlimab and Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma
Sir Run Run Shaw Hospital
A Study of Trifluridine/Tipiracil Combined With Anlotinib as Second-line Treatment for Recurrent and Metastatic Esophageal Squamous Cell Carcinoma
First Affiliated Hospital of Zhejiang University
Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma
Sun Yat-sen University
Real-world Study of Sacituzumab Govitecan Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
Peking University Cancer Hospital & Institute
Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Multimodal Managements for Metastatic Pancreatic Cancer.
Zhejiang University
A Study Comparing the Differences Between Young and Non-young Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective Study
Seoul National University Bundang Hospital
TransValid-A
University Medical Center Goettingen
Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC
Shengjing Hospital
Pyrotinib Maleate, CDK4/6 Inhibitor and Letrozole in Combination for Stage II-III TPBC: a Phase II Trial
Shengjing Hospital
Study on the Biomarker of First-line Immunotherapy Combined With Chemotherapy in Advanced Esophageal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian Cancer
Tongji Hospital
RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM
SCRI Development Innovations, LLC
ATNPA
The First Affiliated Hospital with Nanjing Medical University
Sintilimab, Anlotinib Hydrochloride and Platinum-Containing Dual-Agent Chemotherapy in NSCLC
The First Affiliated Hospital with Nanjing Medical University
Combination of Anti-PD-1 Antibody and Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma
Zhejiang University
Multimodal Intervention for Patients With Non-small Cell Lung Cancer
Aalborg University Hospital
Combined Ipsilateral Liver Lobe Devascularization and Alcohol Treatment of the Large Hepatocellular Carcinoma
The National Ribat University
Multimodal Analgesia in Major Abdominal Pediatric Cancer Surgeries
National Cancer Institute, Egypt
Conducting Outreach to Improve Cervical Cancer Screening Rates Among Underscreened Patients
Fenway Community Health
Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer
SCRI Development Innovations, LLC
Phase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
New Mexico Cancer Research Alliance
FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only
SCRI Development Innovations, LLC
LYMPHATIC
University of Malaga
Neo-adjuvant Chemo + Peritonectomy + Hyperthermic Intraperitoneal Chemo in Peritoneal Carcinomatosis From Gastric Cancer
Uppsala University
Comparing Population Cessation Services
University of Rhode Island
Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery
Mayo Clinic